Literature DB >> 31371864

Nasal Glucagon: A Promising New Way to Treat Severe Hypoglycemia.

Lynn H Nguyen1, John R White1.   

Abstract

Entities:  

Year:  2019        PMID： 31371864      PMCID： PMC6640878          DOI： 10.2337/cd19-0013

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN： 0891-8929


× No keyword cloud information.
  3 in total

1.  Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.

Authors:  Michael R Rickels; Katrina J Ruedy; Nicole C Foster; Claude A Piché; Hélène Dulude; Jennifer L Sherr; William V Tamborlane; Kathleen E Bethin; Linda A DiMeglio; R Paul Wadwa; Andrew J Ahmann; Michael J Haller; Brandon M Nathan; Santica M Marcovina; Emmanouil Rampakakis; Linyan Meng; Roy W Beck
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

2.  Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.

Authors:  Jennifer L Sherr; Katrina J Ruedy; Nicole C Foster; Claude A Piché; Hélène Dulude; Michael R Rickels; William V Tamborlane; Kathleen E Bethin; Linda A DiMeglio; Larry A Fox; R Paul Wadwa; Desmond A Schatz; Brandon M Nathan; Santica M Marcovina; Emmanouil Rampakakis; Linyan Meng; Roy W Beck
Journal:  Diabetes Care       Date:  2016-02-16       Impact factor: 19.112

3.  Effects of common cold and concomitant administration of nasal decongestant on the pharmacokinetics and pharmacodynamics of nasal glucagon in otherwise healthy participants: A randomized clinical trial.

Authors:  Cristina B Guzman; Helene Dulude; Claude Piché; Marianne Rufiange; Aziz A Sadoune; Emmanouil Rampakakis; Dolores Carballo; Myriam Triest; Michelle Xiaotian Zhang; Shuyu Zhang; Maryam Tafreshi; Eric Sicard
Journal:  Diabetes Obes Metab       Date:  2017-11-19       Impact factor: 6.577
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.